Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: A meta-analysis

Chen, Ge; Liu, Shanglong; Zhao, Yupei; Dai, Menghua; Zhang, Taiping

doi:10.1016/j.pan.2013.01.013

Cited by 147 publications

(98 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…overall, the accuracy of eus fna in these indications is between 85% and 97%. [4][5][6][7] Recurrences of CRC arise from residual tumor cells in the perirectal fat or lymph nodes missed at surgery. as a consequence, they are usually found in the anastomosis or in the surrounding tissue and can be easily targeted by eus fna.…”

mentioning

confidence: 99%

Endoscopic Ultrasound-Guided Fine Needle Aspiration Is Highly Accurate for the Diagnosis of Perirectal Recurrence of Colorectal Cancer

Fernández‐Esparrach

Alberghina

Súbtil

et al. 2015

Diseases of the Colon &Amp; Rectum

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Endoscopic Ultrasound-Guided Fine Needle Aspiration Is Highly Accurate for the Diagnosis of Perirectal Recurrence of Colorectal Cancer

Fernández‐Esparrach

Alberghina

Súbtil

et al. 2015

Diseases of the Colon &Amp; Rectum

View full text Add to dashboard Cite

show abstract

“…It can be used to confirm the existence of a pNEN and to provide prognostic information by the determination of the Ki67 index and tissue grading (Larghi et al 2012, Rindi et al 2012, Farrell et al 2014. In two previous meta-analyses, a pooled sensitivity up to 86% and a specificity of 95% for the correct pathology in solid pancreatic lesions in non-MEN1 patients was reported (Chen et al 2013, Puli et al 2013). In the setting of MEN1, however, there is no role for routine use of EUS-FNA, since it is obvious that any lesion in the pancreas will be most likely a pNEN.…”

Section: :10mentioning

confidence: 99%

The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies

Manoharan¹,

Albers²,

Bartsch³

2017

Endocrine-Related Cancer

View full text Add to dashboard Cite

Prospective randomized data are lacking, but current clinical expert guidelines recommend annual screening examinations, including laboratory assessments and various imaging modalities (e.g. CT, MRI, scintigraphy and EUS) for patients with multiple endocrine neoplasia type 1 (MEN1). Routine screening is proposed to detect and localize neuroendocrine manifestations as early as possible. The goal is timely intervention to improve quality of life and to increase life expectancy by preventing the development of life-threatening hormonal syndromes and/or metastatic disease. In recent years, some studies compared different and new imaging methods regarding their sensitivity and utility in MEN1 patients. This present article reviews the proposed diagnostic tools for MEN1 screening as well as potential future perspectives.

show abstract

“…On a recent meta-analysis of 31 articles, this procedure showed an area under the receiver operating characteristic (ROC) curve value of 0.97 indicating a good performance and high overall accuracy [38]. This technique is not only useful in obtaining tissue for cytology or histology, lately the use of molecular markers coupled with EUS-FNA to improve its accuracy is under investigation.…”

Section: • • Pancreatic Cystic Lesions and The Importance Of Endoscopymentioning

confidence: 99%

State-Of-The-Art Endoscopic Procedures for Pancreatic Cancer

Coronel

Waxman

2016

Future Oncol.

View full text Add to dashboard Cite

Pancreatic cancer is the twelfth most common cancer worldwide, taking the fourth place in cancer-related mortality in western countries. Despite significant efforts in understanding the tumor biology of pancreatic cancer and introducing new technologies and therapies to improve the detection, staging and treatment of this disease, pancreatic cancer continues to have a high and almost unchanged mortality. In the last few decades, the development of techniques such as endoscopic retrograde cholangio pancreatography and endoscopic ultrasound have allowed us to directly access the pancreaticobiliary system and fight pancreatic cancer and its complications from different fronts. Our goal with this review is to discuss the most cutting-edge endoscopic techniques available in our armamentarium to diagnose, stage and treat pancreatic cancer.

show abstract

Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: A meta-analysis

Cited by 147 publications

References 58 publications

Endoscopic Ultrasound-Guided Fine Needle Aspiration Is Highly Accurate for the Diagnosis of Perirectal Recurrence of Colorectal Cancer

Endoscopic Ultrasound-Guided Fine Needle Aspiration Is Highly Accurate for the Diagnosis of Perirectal Recurrence of Colorectal Cancer

The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies

State-Of-The-Art Endoscopic Procedures for Pancreatic Cancer

Contact Info

Product

Resources

About